The Latest Cardiac and Vascular News
SAN FRANCISCO, February 19, 2018 /PRNewswire/ — The global cardiac rhythm management (CRM) devices market size is anticipated to reach USD 32.4 billion by 2025, according to a new report by Grand View Research, Inc., registering a 7.8% CAGR during the forecast period. Increase in demand for CRM devices can be attributed to supportive legislative policies […]
MINNESOTA, United States–(BUSINESS WIRE)– Osprey Medical Inc.(ASX:OSP) today announced a multi-center observational study for the DyeVert Plus™ System will feature at the Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Session in April 2018. The abstract entitled: A Multi-Center Observational Study of the DyeVert Plus™ Contrast Reduction System summarizes a single-arm, multi-center observational […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Insight, Inc., a leading U.S. developer of wearable medical devices and diagnostic software, announced today the company continues to garner global interest in its approach to cardiac care, and has added renowned cardiologists and atrial fibrillation (AFib) specialists, Professor John Camm and Albert L. Waldo, MD, PhD […]
SAN FRANCISCO, Feb. 15, 2018 /PRNewswire/ — Arterys Inc., the leader in intelligent, cloud-based medical imaging software solutions, today announced its fifth 510(k) clearance from the U.S. Food and Drug Administration (FDA). The clearance is for the Arterys Oncology AI suite, and is a milestone indicative of the company’s momentum in applying AI […]
TEL AVIV, Israel, Feb. 15, 2018 /PRNewswire/ — Perflow Medical, an Israeli-based medical device company that develops innovative tools for neurovascular interventions, today announced that the company has closed $12 million in financing. The syndicate included existing investors, two new international investors, and an unnamed strategic investor. Following a recent launch in Europe, Perflow stated that […]
FRANKLIN LAKES, N.J., Feb. 15, 2018 /PRNewswire/ — Becton, Dickinson and Company (NYSE: BDX), a leading global medical technology company, announced today that it has completed the previously announced divestitures of its soft tissue core needle biopsy product line and Aspira® product line to Merit Medical Systems, Inc. following receipt of all required […]
IRVINE, Calif., Feb. 15, 2018 /PRNewswire/ — Edwards Lifesciences(NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced it has received CE Mark for its self-expanding CENTERA valve for severe, symptomatic aortic stenosis patients at high risk of open-heart surgery. The Edwards CENTERA […]
HeartFlow Completes Series E Financing, Securing $240 Million Proceeds Will Support Commercialization of HeartFlow® FFRct Analysis, Continued Technology Innovation and Additional Clinical Studies REDWOOD CITY, Calif.–(BUSINESS WIRE)– HeartFlow. today announced the closing of its Series E financing, securing $240 million. The company will use the proceeds from this financing to ramp up commercial […]
LivaNova to Acquire TandemLife Company will add advanced cardiopulmonary temporary support solutions to its portfolio LONDON–(BUSINESS WIRE)– LivaNova PLC (NASDAQ:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology company, today announced it has entered into an agreement to acquire TandemLife, a privately held company focused on advanced cardiopulmonary temporary support solutions (“TandemLife”). The […]
IRVINE, California and DENVER, Colorado, February 13, 2018 – McDermott & Bull announced today the acquisition of Denver-based Prime-Core Executive Search and the addition of Ken Dropiewski as Principal Consultant. Dropiewski will join the firm’s Life Sciences Group, specializing in the Med-Tech space. “The addition of Ken to our firm is a huge […]
